Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease.

de Borst MH, Vervloet MG, ter Wee PM, Navis G.

J Am Soc Nephrol. 2011 Sep;22(9):1603-9. doi: 10.1681/ASN.2010121251. Epub 2011 Aug 18.

PMID:
21852584
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Pathologies of calcium-phosphate homeostasis].

Karczmarewicz E, Czekuć-Kryskiewicz E, Lorenc RS.

Postepy Biochem. 2012;58(4):474-7. Review. Polish.

PMID:
23662440
[PubMed - indexed for MEDLINE]
3.

[FGF-23 and Klotho protein - new markers in chronic kidney disease?].

Mituła I, Gołembiewska E, Ciechanowski K, Siuda A.

Pol Merkur Lekarski. 2013 Apr;34(202):235-8. Review. Polish.

PMID:
23745333
[PubMed - indexed for MEDLINE]
4.

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, Hsiao LL.

Circulation. 2012 May 8;125(18):2243-55. doi: 10.1161/CIRCULATIONAHA.111.053405. Epub 2012 Apr 5.

PMID:
22492635
[PubMed - indexed for MEDLINE]
Free Article
5.

Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.

Prié D, Friedlander G.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1717-22. doi: 10.2215/CJN.02680310. Epub 2010 Aug 26. Review.

PMID:
20798257
[PubMed - indexed for MEDLINE]
Free Article
6.

Can vitamin D slow down the progression of chronic kidney disease?

Shroff R, Wan M, Rees L.

Pediatr Nephrol. 2012 Dec;27(12):2167-73. doi: 10.1007/s00467-011-2071-y. Epub 2011 Dec 10. Review.

PMID:
22160397
[PubMed - indexed for MEDLINE]
7.

Klotho and chronic kidney disease.

Hu MC, Kuro-o M, Moe OW.

Contrib Nephrol. 2013;180:47-63. doi: 10.1159/000346778. Epub 2013 May 3. Review.

PMID:
23652549
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Role of Klotho in aging, phosphate metabolism, and CKD.

John GB, Cheng CY, Kuro-o M.

Am J Kidney Dis. 2011 Jul;58(1):127-34. doi: 10.1053/j.ajkd.2010.12.027. Epub 2011 Apr 15. Review.

PMID:
21496980
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.

de Brito Galvao JF, Nagode LA, Schenck PA, Chew DJ.

J Vet Emerg Crit Care (San Antonio). 2013 Mar-Apr;23(2):134-62. doi: 10.1111/vec.12036. Review.

PMID:
23566108
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity?

Bacchetta J, Salusky IB, Hewison M.

Pediatr Nephrol. 2013 Apr;28(4):577-82. doi: 10.1007/s00467-012-2336-0. Epub 2012 Nov 2. Review.

PMID:
23117582
[PubMed - indexed for MEDLINE]
11.

Fibroblast growth factor 23--structure, function and role in kidney diseases.

Kocełak P, Olszanecka-Glinianowicz M, Chudek J.

Adv Clin Exp Med. 2012 May-Jun;21(3):391-401. Review.

PMID:
23214203
[PubMed - indexed for MEDLINE]
Free Article
12.

FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?

Razzaque MS.

Adv Exp Med Biol. 2012;728:84-91. doi: 10.1007/978-1-4614-0887-1_5. Review.

PMID:
22396163
[PubMed - indexed for MEDLINE]
13.

FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.

Wöhrle S, Bonny O, Beluch N, Gaulis S, Stamm C, Scheibler M, Müller M, Kinzel B, Thuery A, Brueggen J, Hynes NE, Sellers WR, Hofmann F, Graus-Porta D.

J Bone Miner Res. 2011 Oct;26(10):2486-97. doi: 10.1002/jbmr.478.

PMID:
21812026
[PubMed - indexed for MEDLINE]
14.

Vitamin D in chronic kidney disease: new potential for intervention.

Mirković K, van den Born J, Navis G, de Borst MH.

Curr Drug Targets. 2011 Jan;12(1):42-53. Review.

PMID:
20795938
[PubMed - indexed for MEDLINE]
15.

Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.

Krajisnik T, Olauson H, Mirza MA, Hellman P, Akerström G, Westin G, Larsson TE, Björklund P.

Kidney Int. 2010 Nov;78(10):1024-32. doi: 10.1038/ki.2010.260. Epub 2010 Aug 4.

PMID:
20686451
[PubMed - indexed for MEDLINE]
16.

Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.

Scholze A, Liu Y, Pedersen L, Xia S, Roth HJ, Hocher B, Rasmussen LM, Tepel M.

J Clin Endocrinol Metab. 2014 May;99(5):E855-61. doi: 10.1210/jc.2013-4171. Epub 2014 Feb 25.

PMID:
24606097
[PubMed - indexed for MEDLINE]
17.

The role of FGF23 in CKD--with or without Klotho.

Komaba H, Fukagawa M.

Nat Rev Nephrol. 2012 Jun 19;8(8):484-90. doi: 10.1038/nrneph.2012.116. Review.

PMID:
22714041
[PubMed - indexed for MEDLINE]
18.

Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.

Sakan H, Nakatani K, Asai O, Imura A, Tanaka T, Yoshimoto S, Iwamoto N, Kurumatani N, Iwano M, Nabeshima Y, Konishi N, Saito Y.

PLoS One. 2014 Jan 23;9(1):e86301. doi: 10.1371/journal.pone.0086301. eCollection 2014.

PMID:
24466013
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Updates on rickets and osteomalacia: various roles of Klotho and FGF23 in vivo ].

Imura A.

Clin Calcium. 2013 Oct;23(10):1476-82. doi: CliCa131014761482. Review. Japanese.

PMID:
24076646
[PubMed - indexed for MEDLINE]
20.

Klotho gene, phosphocalcic metabolism, and survival in dialysis.

Torres PU, Prié D, Beck L, De Brauwere D, Leroy C, Friedlander G.

J Ren Nutr. 2009 Jan;19(1):50-6. doi: 10.1053/j.jrn.2008.10.018. Review.

PMID:
19121771
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk